News

Roche collaborates with Lilly to support people with diabetes on insulin pen therapy

● Roche and Lilly will integrate data from Lilly’s connected insulin pen solution into the mySugr app in several…

Nabriva Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates

-First quarter of full complement of 60 sales representatives further expanding the reach of XENLETA® (lefamulin) and…

Uni Wien: Fleißiger als Bienen: Vögel und Fledermäuse bestäuben Pflanzen der Anden

Im Lauf der Evolution wechselten Bestäuber in Bergregenwäldern

Valneva Announces the Pricing of its Initial Public Offering on Nasdaq

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for…

MedUni Wien: Winzigsten Kräften auf der Spur: wie T-Zellen Eindringlinge erkennen

T-Zellen benutzen ihre Antigen-Rezeptoren wie klebrige Finger – ein Team der TU Wien und der MedUni Wien konnte sie…

Valneva Announces an Indicative Price Range of its previously announced Proposed Global Offering

Valneva SE (the “Company”), a specialty vaccine company focused on the development and commercialization of prophylactic…

CEBINA reports potency of azelastine against emerging dominant variants of SARSCoV-2 in laboratory testing

CEBINA GmbH, an Austrian biotech company, today announces that azelastine, previously identified as a potential…

HeartBeat.bio AG to Reinvent Cardiac Drug Discovery

- World-wide first self-organizing human cardiac organoids (Cardioids) for high-throughput drug screening

- Technology…

MedUni Vienna: Women with bladder cancer have poorer outcomes than men

May is International Bladder Cancer Awareness Month – MedUni Vienna experts advocate sex-specific and personalised…

JLP: Neue Wege zum Erfolg in der Krebs- und Virenforschung

Zwei bedeutende und international agierende Stiftungen aus dem Innviertel sind die neuen strategischen Partner der JLP…

Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of…

MedUni Vienna: Important factor in the development of dendritic cells identified

The human immune system comprises functionally specialised cellular defence mechanisms that protect the body against…

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.